Kfa Private Wealth Group, LLC Amgen Inc Transaction History

Kfa Private Wealth Group, LLC

$209 Million
Q3 2024

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 01, 2024	BUY	$268.87 - $324.56 $87,113 - $105,157	324 Added 22.69%	1,752 $498,000
Q4 2023 Feb 02, 2024	BUY	$255.7 - $288.46 $24,547 - $27,692	96 Added 7.21%	1,428 $411,000
Q3 2023 Oct 25, 2023	SELL	$218.65 - $271.46 $8,090 - $10,044	-37 Reduced 2.7%	1,332 $357,000
Q2 2023 Jul 18, 2023	SELL	$214.27 - $253.37 $23,569 - $27,870	-110 Reduced 7.44%	1,369 $303,000
Q1 2023 May 05, 2023	BUY	$225.79 - $275.2 $21,224 - $25,868	94 Added 6.79%	1,479 $357,000
Q4 2022 Jan 31, 2023	BUY	$229.03 - $291.01 $24,048 - $30,556	105 Added 8.2%	1,385 $363,000
Q3 2022 Nov 02, 2022	SELL	$224.46 - $253.15 $4,040 - $4,556	-18 Reduced 1.39%	1,280 $288,000
Q2 2022 Jul 18, 2022	SELL	$230.71 - $256.74 $1,153 - $1,283	-5 Reduced 0.38%	1,298 $316,000
Q1 2022 May 02, 2022	SELL	$219.27 - $242.57 $2,850 - $3,153	-13 Reduced 0.99%	1,303 $315,000
Q4 2021 Jan 26, 2022	SELL	$198.88 - $227.6 $31,025 - $35,505	-156 Reduced 10.6%	1,316 $296,000
Q3 2021 Oct 18, 2021	BUY	$212.27 - $248.7 $12,099 - $14,175	57 Added 4.03%	1,472 $313,000
Q2 2021 Jul 22, 2021	SELL	$233.58 - $259.14 $14,949 - $16,584	-64 Reduced 4.33%	1,415 $345,000
Q1 2021 May 06, 2021	BUY	$221.91 - $258.6 $16,421 - $19,136	74 Added 5.27%	1,479 $368,000
Q4 2020 Mar 08, 2021	BUY	$216.38 - $257.67 $11,900 - $14,171	55 Added 4.07%	1,405 $323,000
Q3 2020 Nov 04, 2020	BUY	$234.65 - $260.95 $38,247 - $42,534	163 Added 13.73%	1,350 $343,000
Q2 2020 Jul 28, 2020	SELL	$197.81 - $242.74 $13,846 - $16,991	-70 Reduced 5.57%	1,187 $280,000
Q1 2020 Apr 23, 2020	BUY	$182.24 - $241.7 $20,957 - $27,795	115 Added 10.07%	1,257 $255,000
Q4 2019 Jan 28, 2020	BUY	$189.21 - $243.2 $216,077 - $277,734	1,142 New	1,142 $275,000

Others Institutions Holding AMGN

# of Institutions

3,122

Shares Held

410M

Call Options Held

7.56M

Put Options Held

7.2M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $158B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Kfa Private Wealth Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Kfa Private Wealth Group, LLC with notifications on news.

Account